ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 40 filers reported holding ENOCHIAN BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,355,169 | +1434.6% | 303,094 | +94.5% | 0.00% | – |
Q2 2023 | $88,310 | -69.7% | 155,861 | -51.1% | 0.00% | – |
Q1 2023 | $291,784 | +88858.5% | 318,855 | +0.0% | 0.00% | – |
Q4 2022 | $328 | -99.9% | 318,783 | +0.0% | 0.00% | – |
Q3 2022 | $576,000 | -6.3% | 318,659 | -0.1% | 0.00% | – |
Q2 2022 | $615,000 | -50.6% | 319,011 | +111.4% | 0.00% | – |
Q1 2022 | $1,245,000 | +11.7% | 150,917 | -1.4% | 0.00% | – |
Q4 2021 | $1,115,000 | -20.1% | 153,085 | -26.2% | 0.00% | – |
Q3 2021 | $1,396,000 | +89.9% | 207,568 | +40.2% | 0.00% | – |
Q2 2021 | $735,000 | -29.4% | 148,059 | -49.7% | 0.00% | – |
Q1 2021 | $1,041,000 | +24.4% | 294,239 | +3.6% | 0.00% | – |
Q4 2020 | $837,000 | -16.4% | 284,034 | +1.6% | 0.00% | – |
Q3 2020 | $1,001,000 | -12.2% | 279,672 | +3.3% | 0.00% | – |
Q2 2020 | $1,140,000 | +48.4% | 270,820 | +5.7% | 0.00% | – |
Q1 2020 | $768,000 | -64.9% | 256,100 | -41.3% | 0.00% | – |
Q4 2019 | $2,188,000 | +612.7% | 436,072 | +681.1% | 0.00% | – |
Q3 2019 | $307,000 | +27.9% | 55,826 | +4.3% | 0.00% | – |
Q2 2019 | $240,000 | – | 53,519 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
Ergoteles LLC | 47,984 | $238,000 | 0.01% |
Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
UBS Group AG | 260 | $1,000 | 0.00% |